Masayuki Arakawa Selected Research

Masayuki Arakawa Research Topics

Disease

4	Hyperglycemia 10/2013 - 11/2006
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2018 - 10/2014
3	Thrombosis (Thrombus) 01/2013 - 10/2009
3	Neoplasms (Cancer) 07/2008 - 03/2007
3	Prostatic Neoplasms (Prostate Cancer) 07/2008 - 03/2007
3	Inborn Genetic Diseases (Disease, Hereditary) 02/2008 - 11/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2011 - 11/2006
2	Atherosclerosis 09/2008 - 11/2006
2	Muscular Dystrophies (Muscular Dystrophy) 02/2008 - 11/2004
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2004 - 11/2003
1	Hypoxia (Hypoxemia) 07/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Needlestick Injuries (Needlestick Injury) 11/2014
1	Atherosclerotic Plaque (Atheroma) 01/2013
1	Type 2 Diabetes Mellitus (MODY) 02/2011
1	Body Weight (Weight, Body) 02/2011
1	Vascular System Injuries 02/2011
1	Weight Gain 12/2009
1	Insulin Resistance 10/2008
1	Diabetes Mellitus 12/2007
1	Hepatitis 12/2007
1	Hepatocellular Carcinoma (Hepatoma) 12/2007
1	Myocardial Infarction 05/2007
1	Ischemia 05/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 07/2020 - 05/2007
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2006
3	CarrageenanIBA 01/2013 - 10/2009
3	Nonsense Codon (Nonsense Mutation)IBA 02/2008 - 11/2003
3	DystrophinIBA 11/2004 - 11/2003
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2013 - 11/2006
2	Insulin (Novolin)FDA Link 10/2013 - 09/2008
2	LipidsIBA 01/2013 - 09/2008
2	Exenatide (Byetta)FDA Link 02/2011 - 12/2009
2	Glucose (Dextrose)FDA LinkGeneric 12/2009 - 12/2007
2	angiogeninIBA 07/2008 - 03/2007
2	AndrogensIBA 07/2008 - 03/2007
2	Peptide Hydrolases (Proteases)FDA Link 03/2008 - 05/2004
2	DipeptidesIBA 11/2004 - 11/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2004 - 11/2003
2	AminoglycosidesIBA 11/2004 - 11/2003
2	negamycinIBA 11/2004 - 11/2003
1	cobaltous chloride (cobalt(II)chloride)IBA 07/2020
1	Messenger RNA (mRNA)IBA 07/2020
1	MyogeninIBA 07/2020
1	PlasticsIBA 11/2014
1	Liraglutide FDA Link 10/2013
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2011
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2011
1	Platelet-Derived Growth FactorIBA 02/2011
1	nattokinaseIBA 01/2010
1	Pharmaceutical PreparationsIBA 10/2009
1	Nonesterified Fatty Acids (NEFA)IBA 10/2008
1	Glycoside Hydrolase InhibitorsIBA 09/2008
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2008
1	GlucosidesIBA 07/2008
1	terreinIBA 07/2008
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 03/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2008
1	Insulin-Like Growth Factor Binding Protein 3IBA 03/2008
1	Codon (Codons)IBA 02/2008
1	Blood Glucose (Blood Sugar)IBA 12/2007
1	Androgen Receptors (Androgen Receptor)IBA 03/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	Insulin SecretagoguesIBA 11/2006
1	Gentamicins (Gentamicin)FDA LinkGeneric 11/2004
1	Complementary DNA (cDNA)IBA 05/2004

Therapy/Procedure

3	Therapeutics 10/2013 - 03/2007
1	Ligation 10/2009
1	Radiofrequency Ablation 12/2007
1	Glycemic Control 11/2006
1	Drug Therapy (Chemotherapy) 11/2004